Terms of Use
Last updated: September 24, 2025
Acceptable Use Policy
Clients must use COADIA services only for lawful clinical, research, medical affairs, or pharmacovigilance purposes, without attempting to breach security, disrupt service, or misuse patient data.
Client Responsibilities
You Control Your Data
- Configure consent settings and inform patients and participants as required by your policies and law
- Provide and manage your user accounts and authentication sources
- Classify your data, define retention needs, and instruct us on deletion or return at the end of the term
- Review and approve all clinical documentation and coded outputs before downstream use
Data Confidentiality Commitments
We commit to protect client confidential information, limit access to authorized personnel, and use information solely to provide contracted services. A concise confidentiality statement improves contract alignment and mirrors what buyers expect to see publicly.
International Data Transfers
When client data is stored or accessed outside its origin region, we will support appropriate transfer mechanisms, such as EU Standard Contractual Clauses, UK International Data Transfer Addendum, or other agreed safeguards.
De-identification and Research Use
De-identification
We support de-identification configurations before sponsor facing processing. This includes redaction of direct identifiers in transcripts and removal or masking of identifiers in audio features.
Research
If a project involves research under IRB or ethics board oversight, clients are responsible for approvals and participant disclosures. We implement the data handling and audit controls specified by the protocol and contract.
Product Specific Notes for CNS and Psychiatry
Clinical Assessments
When configured, COADIA can deliver digitized clinical assessments with auto scoring and EMR write back. These assessments are designed for CNS and psychiatric conditions across various care settings. Sponsors should validate workflows locally and follow clinical guidelines.
Pharmacovigilance Alignment
Our adverse event signals are coded with MedDRA to align with PV systems and downstream reporting.